Academic Journal
Q1JACC: Advances
About JACC: Advances
JACC: Advances is a scholarly journal published by Elsevier B.V.. SCImago 2025 lists it in Q1, with an SJR of 1.717 and H-index of 26.
Coverage: 2022-2026. Research categories: Cardiology and Cardiovascular Medicine (Q1).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Cardiovascular Function and Risk Factors; Cardiac Valve Diseases and Treatments; Congenital Heart Disease Studies; Cardiac Imaging and Diagnostics; Heart Failure Treatment and Management; Atrial Fibrillation Management and Outcomes.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Association of Predicted Surgical Risk With 3-Year Outcomes After Isolated Tricuspid Valve Surgery
J Hunter Mehaffey, David J. Cohen, Charles Davidson, Rebecca Hahn et al.
2026-11 · DOI: 10.1016/j.jacadv.2026.103297A Knowledge Graph Framework for Longitudinal Congenital Heart Disease Modeling
Hang Xu, Lila Cunge, Zhengyang Ming, Siyan Chen et al.
2026-11 · DOI: 10.1016/j.jacadv.2026.103291Absence of Fibrosis Influences Prognosis of Cardiac Resynchronization in Nonischemic Cardiomyopathy
Jesús Sánchez-Vega, Ignasi Anguera, Francisco Leyva, Otto A. Smiseth et al.
2026-11 · DOI: 10.1016/j.jacadv.2026.103295Factors Associated With Right Ventricular Size Recovery After Transcatheter Closure of Isolated Atrial Septal Defects
Michael N. Gritti, Sara Pollanen, Olivia Carere, Rajiv R. Chaturvedi et al.
2026-11 · DOI: 10.1016/j.jacadv.2026.103304Cholesterol Management Gaps Among Patients With Established Coronary Artery Disease Hospitalized for Acute Coronary Events
Lisandro D. Colantonio, Zhixin Wang, Stephen L. Sigal, Emily B. Levitan et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103207Life-Course Noncardiac Comorbidity Burden and Mortality in Lower-Complexity Congenital Heart Disease
Jie-Xin Zhang, Meng-Yi Liu, Pei-Er Chen, Jia-Xing Zhang et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103278Intravascular Imaging-Guided Percutaneous Coronary Intervention for Calcified Coronary Lesions
Giuseppe Panuccio, Youssef S. Abdelwahed, Giuseppe Tartaglione, Nicole Carabetta et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103237Sex Differences in Coronary Atheroma Regression After Intensive Lipid-Lowering Therapy
Agam Bansal, Julie St. John, Rishi Puri, Stephen J. Nicholls et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103243Mural Right-Sided Infective Endocarditis in Adults
Guillermo Cuervo, Supavit Chesdachai, Joya-Rita Hindy, Danielle Gerberi et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103253Clinician and Patient Perspectives on Cardiac Rehabilitation for Type 1 vs Type 2 Myocardial Infarction
Connor Suscha, Seán P. Murphy, Nhi Tong, Jeff C. Huffman et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103230Evolving Evidence-Driven Strategies in Cardiogenic Shock Management
Anju Bhardwaj, Dustin Hillerson, Nikhil Narang, Megan N. Pelter et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103225Hospital Financial Structure and Unplanned Rehospitalization Following Acute Myocardial Infarction in the United States
Preston Leung, Jaden Rahmani, Owen Lai, Giselle Porter et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103218Coronary Plaque Burden in South Asian Adults
Ahmed Mustafa Rashid, Sashwath Srikanth, Neeka Tavanaei, Swapnil Gupta et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103235Teaching the Heart Before It Breaks
Ramzi Ibrahim
2026-10 · DOI: 10.1016/j.jacadv.2026.103232Peripartum Cardiomyopathy Genetic Screening Protocol and Registry
Pooja Choubey, Kelly Araujo, Vanessa Montoya-Uribe, Robert C. Moore et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103286Objective and Subjective Multidimensional Sleep Health in Women After Myocardial Infarction
Olivia C. Liu, Milla Arabadjian, Anais Hausvater, Chorong Park et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103194Left Atrial Appendage Occlusion vs Direct Oral Anticoagulants for Atrial Fibrillation
Yuriko Hiruma, Tadao Aikawa, Iwanari Kawamura, Masao Iwagami et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103269Using CK-MB and hs-cTnT to Predict 30-Day Mortality After CABG
Winter-Pölzl Leo, Kletzer Joseph, Lohmann Ronja, Engler Clemens et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103284Association Between the Degree of Extravalvular Cardiac Damage and the Severity of Aortic Stenosis
Augustin Coisne, Rubens Groulez, Camille Diharce, David Montaigne et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103227Impact of Downregulated Inflammation via the IL6R Asp358Ala Variant on Atrial Fibrillation Recurrence Following Ablation
Jitae A. Kim, Jisong J. Kim, Caique M.P. Ternes, Mihail G. Chelu et al.
2026-10 · DOI: 10.1016/j.jacadv.2026.103285Reviews
Community Reviews
Version History
October 4, 2026 at 8:49 pm
September 25, 2026